Literature DB >> 16170534

The effect of digital measurement software on photodynamic therapy.

Siamak Ansari-Shahrezaei1, Erdem Ergun, Michael Stur.   

Abstract

BACKGROUND: To investigate the effect of refraction-corrected digital measurement software on photodynamic therapy (PDT) treatment spot size.
METHODS: Experimental study using a calibrated Gullstrand-type model eye. The axial length of the model eye was set to different values, ranging from 20 to 31 mm, and the PDT treatment spot sizes obtained from refraction-corrected digital measurement software and manual measurement with a fixed-magnification factor, as well as four different indirect contact laser lenses, were calculated and compared for a treatment spot with a diameter of 4 mm.
RESULTS: The maximum deviation from the treating laser spot was +39.6% under myopic and +17.4% under hyperopic conditions when the refraction-corrected digital measurement software was used. The maximum deviation was +14.2% under myopic and +13.3% under hyperopic conditions when the manual measurement with the fixed-magnification factor was used.
CONCLUSIONS: The use of refraction-corrected digital measurement software produces a larger deviation from treating laser spot than the use of manual measurement with a fixed-magnification factor. Therefore, refraction-corrected digital measurement software might not be suitable for calculating the recommended PDT treatment spot size in eyes with high refractive errors.

Mesh:

Substances:

Year:  2005        PMID: 16170534     DOI: 10.1007/s00417-005-0128-y

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  12 in total

1.  The effect of axial length on laser spot size and laser irradiance.

Authors:  M Stur; S Ansari-Shahrezaei
Journal:  Arch Ophthalmol       Date:  2001-09

2.  Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.

Authors: 
Journal:  Ophthalmology       Date:  2001-05       Impact factor: 12.079

Review 3.  Lasers, optical systems and safety in ophthalmology: a review.

Authors:  F Fankhauser; U Dürr; H Giger; P Rol; S Kwasniewska
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

4.  Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.

Authors:  Kevin J Blinder; Mark S Blumenkranz; Neil M Bressler; Susan B Bressler; Guy Donato; Hilel Lewis; Jennifer I Lim; Ugo Menchini; Joan W Miller; Jordi M Mones; Michael J Potter; Constantin Pournaras; Al Reaves; Philip Rosenfeld; Andrew P Schachat; Ursula Schmidt-Erfurth; Michel Sickenberg; Lawrence J Singerman; Jason S Slakter; H Andrew Strong; Gianni Virgili; George A Williams
Journal:  Ophthalmology       Date:  2003-04       Impact factor: 12.079

5.  [A model of Gullstrand's "normal eye"].

Authors:  B Rassow
Journal:  Ophthalmologica       Date:  1972       Impact factor: 3.250

6.  Possible errors in the measurement of retinal lesions.

Authors:  J V Arnold; J W Gates; K M Taylor
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-07       Impact factor: 4.799

7.  Improvements on Littmann's method of determining the size of retinal features by fundus photography.

Authors:  A G Bennett; A R Rudnicka; D F Edgar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-06       Impact factor: 3.117

8.  Severe pigment epithelial alterations in the treatment area following photodynamic therapy for classic choroidal neovascularization in young females.

Authors:  Laurence Postelmans; Brigitte Pasteels; Pascale Coquelet; Hind El Ouardighi; Claire Verougstraete; Ursula Schmidt-Erfurth
Journal:  Am J Ophthalmol       Date:  2004-11       Impact factor: 5.258

9.  Concentric retinal pigment epithelium atrophy after a single photodynamic therapy.

Authors:  Joachim Wachtlin; Tim Behme; Heinrich Heimann; Ulrich Kellner; Michael H Foerster
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-05-07       Impact factor: 3.117

10.  Magnification-corrected indirect biomicroscopy of the optic nerve head.

Authors:  Siamak Ansari-Shahrezaei; Michael Stur
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-09-29       Impact factor: 3.117

View more
  4 in total

1.  Magnification-corrected photodynamic therapy.

Authors:  Siamak Ansari-Shahrezaei; Erdem Ergun; Robert Chong; Adnan Tufail; Andreas Wedrich; Michael Stur
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-10-06       Impact factor: 3.117

2.  Intravitreal anti-vascular endothelial growth factor combined with half-fluence photodynamic therapy for choroidal neovascularization in chronic central serous chorioretinopathy.

Authors:  E Smretschnig; S Hagen; C Glittenberg; R Ristl; I Krebs; S Binder; S Ansari-Shahrezaei
Journal:  Eye (Lond)       Date:  2016-03-11       Impact factor: 3.775

3.  The effect of laser unit on photodynamic therapy spot size.

Authors:  Siamak Ansari-Shahrezaei; Susanne Binder; Michael Stur
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-07-27       Impact factor: 3.117

4.  The effect of photodynamic therapy on macular sensitivity in eyes with acute central serous chorioretinopathy.

Authors:  Stefan Hagen; Siamak Ansari-Shahrezaei; Eva Smretschnig; Carl Glittenberg; Ilse Krebs; Alexandra Graf; Susanne Binder
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-08-29       Impact factor: 3.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.